A quality‐adjusted survival time without symptoms or...

  • Main
  • 2020 / 07
  • A quality‐adjusted survival time without symptoms or...
Cancer 2020 / 07

A quality‐adjusted survival time without symptoms or toxicities analysis of glasdegib plus low‐dose cytarabine versus low‐dose cytarabine as initial therapy for acute myeloid leukemia in patients who are not considered candidates for intensive chemotherapy

Solem, Caitlyn T., Bell, Timothy J., Kwon, Youngmin, Cappelleri, Joseph C., Johnson, Courtney, Bhattacharyya, Helen, Hoang, Caroline J., Cortes, Jorge E.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Cancer
DOI:
10.1002/cncr.33072
Date:
July, 2020
File:
PDF, 381 KB
2020
Conversion to is in progress
Conversion to is failed